Is the Air Canada Acquisition Delay a Sign of Denial?

Entering into 2020, Air Canada (TSX:AC) planned to grow its international services with the acquisition of Transat AT (TSX:TRZ). But the COVID-19 pandemic has put its plans on a back burner.

| More on:
Plane on runway, aircraft

Image source: Getty Images.

The year 2020 started on a strong note for Canada’s largest air carrier Air Canada (TSX:AC). In 2019, it made new records in operating revenue ($19 billion), passengers carried (51.5 million), and liquidity ($7.4 billion). These strong earnings drove AC stock to its all-time high of $52.7 in mid-January.

This year, the airline planned to expand its international services, reintroduce Boeing 737 Max aircraft, and close the acquisition of Transat AT (TSX:TRZ).

But the COVID-19 outbreak in March disrupted the airline industry. To contain the coronavirus, global governments banned all non-essential travel. Global airlines grounded their aircraft, which burnt a big hole in their pockets.

In light of the current market environment, the airline industry’s priority has shifted from expanding the business to preserving liquidity. All the acquisition deals signed before the pandemic have come under jeopardy.

The Air Canada-Transat deal before and after the pandemic

In August 2019, AC agreed to acquire Transat, Canada’s third-largest airline that specializes in leisure travel, to expand its network. The deal valued Transat at $720 million, or $18 per share, representing a 260% premium on its original share price of $5.

Even though AC offered such a high premium for the deal, its stock rose 7.7% when the agreement was signed. This indicates the importance of the deal to shareholders.

However, the pandemic has drastically changed the global market conditions for the airline industry. All airlines, including AC, are reducing capacity. The $720 million all-cash deal to acquire Transat will eat away 11% of AC’s $6.5 billion in liquidity.

AC can’t afford to lose such a large amount of cash at a time when it is struggling to survive. Moreover, the pandemic has decreased Transat stock price by 63% to $6, thereby making the value of the AC-Transat deal expensive.

Even though AC and Transat hasn’t made any announcements, the pandemic could delay, revise, or cancel their contract. 

Regulatory approvals delay Air Canada-Transat deal

Apart from the pandemic, the AC-Transat deal is facing scrutiny from Competition Bureau of the government of Canada and the European Commission. The regulators are concerned that the deal will affect competition, as the combined company will command up to 60% share of the trans-Atlantic market.

There is no deadline for the Canadian government’s decision. European Commission launched a 90-day investigation expected to close in September. But it has recently suspended the investigation while waiting for the companies to provide requested data. These regulatory approvals have delayed the deal to the fourth quarter.

According to the original agreement, the transaction was scheduled to close on June 27 with an option to extend the deadline up to December 27, 2020. If AC walks out of the deal, it would have to pay $40 million in termination fee.

Is Air Canada trying to cancel the Transat acquisition?

There are rumours that AC is seeking the Canadian government’s help to cancel the Transat deal. If Transport Minister Marc Garneau does not approve the acquisition until December 27, the contract will automatically stand cancelled, and AC will not have to pay the termination fee. Cormark Securities analyst David Ocampo believes that AC could terminate the deal using force majeure clause for unforeseeable circumstances.

What investors should know

If the AC-Transat deal is terminated, it will have an opposite impact on the two stocks. AC stock will rise by the mid-single-digit as the airline will succeed in preserving cash to withstand the crisis.

Transat stock will fall by the double digits as investors are holding the stock to sell them at $18 per share to AC. Buying into any of the two stocks is a gamble.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Puja Tayal has no position in any of the stocks mentioned.

More on Coronavirus

eat food
Coronavirus

Goodfood Stock Doubles Within Days: Time to Buy?

Goodfood (TSX:FOOD) stock has surged 125% in the last few weeks, so what happened, and should investors hop back on…

Read more »

stock data
Tech Stocks

If I Could Only Buy 1 Stock Before 2023, This Would Be It

This stock is the one company that really doesn't deserve its ultra-low share price, so I'll definitely pick it up…

Read more »

Aircraft Mechanic checking jet engine of the airplane
Coronavirus

Air Canada Stock Fell 5% in November: Is it a Buy Today?

Air Canada (TSX:AC) stock saw remarkable improvements during its last quarter but still dropped 5% with more recession hints. So,…

Read more »

Airport and plane
Coronavirus

Is Air Canada Stock a Buy Today?

Airlines are on the rebound. Does Air Canada stock deserve to be on your buy list?

Read more »

A patient takes medicine out of a daily pill box.
Coronavirus

Retirees: 2 Healthcare Stocks That Could Help Set You up for Life

Healthcare stocks offer an incredible opportunity for growth for those investors who look to the right stocks, such as these…

Read more »

sad concerned deep in thought
Coronavirus

Here’s Why I Just Bought WELL Health Stock

WELL Health stock (TSX:WELL) may be a healthcare stock and a tech stock, but don't let that keep you from…

Read more »

healthcare pharma
Coronavirus

WELL Stock: The Safe Stock Investors Can’t Afford to Ignore

WELL stock (TSX:WELL) fell 68% from peak to trough, and yet there's no good reason as to why. So now…

Read more »

telehealth stocks
Tech Stocks

The Ultimate Growth Stock to Buy With $100 Right Now

After climbing 600%, this growth stock is now down 68%. But it won't be long before other investors catch on.

Read more »